Patent details

EP2250279 Title: ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY

Basic Information

Publication number:
EP2250279
PCT Application Number:
PCT/US/2009/033358
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP097073969
PCT Publication Number:
WO/2009/100309
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY
French Title of Invention:
ANTICORPS ANTI-IFNAR1 AYANT UNE AFFINITÉ RÉDUITE POUR LE LIGAND FC
German Title of Invention:
ANTI-IFNAR1-ANTIKÖRPER MIT REDUZIERTER FC-LIGANDENAFFINITÄT
SPC Number:
LUC00263

Dates

Filing date:
06/02/2009
Grant date:
13/04/2016
EP Publication Date:
13/04/2016
PCT Publication Date:
13/08/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/11/2010
EP B1 Publication Date:
13/04/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
06/02/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/09/2018
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

History of Owners

From:
06/02/2009
To:
14/09/2018

Name:
MedImmune LLC
Address:
One MedImmune Way, Gaithersburg, MD 20878, United States (US)

Agent

Name:
ARONOVA S.A.
From:
12/07/2016
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
WU Herren
Address:
United States (US)

2

Name:
CIBOTTI Ricardo
Address:
United States (US)

3

Name:
KIENER Peter
Address:
United States (US)

4

Name:
COYLE Anthony
Address:
United States (US)

Priority

1

Priority Number:
6962 P
Priority Date:
08/02/2008
Priority Country:
United States (US)

2

Priority Number:
34618 P
Priority Date:
07/03/2008
Priority Country:
United States (US)

3

Priority Number:
49970 P
Priority Date:
02/05/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/28;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2018/11
Publication date:
11/10/2018
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20180000304A
Date Registered:
14/09/2018
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
ARONOVA S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
18
Annual Fee Amount:
262 Euro
Expected Payer:
Last Annual Fee Payment Date:
21/01/2025
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
14/09/2018 Request For Change 4
19/09/2018 Outgoing Correspondence 1